Cargando…
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
BACKGROUND: Despite major advancements in immunotherapy among a number of solid tumors, response rates among ovarian cancer patients remain modest. Standard treatment for ovarian cancer is still surgery followed by taxane- and platinum-based chemotherapy. Thus, there is an urgent need to develop nov...
Autores principales: | Hartl, Christina A., Bertschi, Adrian, Puerto, Regina Bou, Andresen, Carolin, Cheney, Emily M., Mittendorf, Elizabeth A., Guerriero, Jennifer L., Goldberg, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668091/ https://www.ncbi.nlm.nih.gov/pubmed/31362778 http://dx.doi.org/10.1186/s40425-019-0654-5 |
Ejemplares similares
-
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
por: von Roemeling, Christina A., et al.
Publicado: (2020) -
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
por: Lal, Jessica Castrillon, et al.
Publicado: (2021) -
CRISPR-Mediated Editing of the B Cell Receptor in Primary Human B Cells
por: Greiner, Vera, et al.
Publicado: (2019) -
Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients
por: Kniotek, Monika, et al.
Publicado: (2017) -
Elucidating Specificity Opens a Window to the Complexity of Both the Innate and Adaptive Immune Systems
por: Belz, Gabrielle T.
Publicado: (2020)